Fusion Antibodies PLC has released an investor presentation, accessible through a provided link. The presentation likely contains detailed information about the company's current status, future plans, and financial performance. Investors and stakeholders are encouraged to review the presentation for a comprehensive understanding of Fusion Antibodies' operations and outlook. For any inquiries, individuals are directed to contact Walbrook PR. The company also provides an option for subscribers to remove themselves from the mailing list. This communication serves as a notification to subscribers of the availability of the investor presentation.